NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (NAMSW)

CUSIP: N62509117

Q2 2025 13F Holders as of 30 Jun 2025

Share change
-3,138
SEC-reported price per share
$8.00
Indexed holders
10
Value change
-$24,954
Number of buys
2
Number of sells
2

Security key

N62509117

Report period

Q2 2025

Indexed institutions

10

Top holders

9

Ownership snapshot

Top reported holders of NAMSW - NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ForGrowth NAP B.V.
Disclosed value leader
Frazier Life Sciences Man...
Comparable rows
0/15
Latest evidence
31 Mar 2025
3/4/5 13F Highest disclosed value: $334,401,070 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Frazier Life Sciences Management, L.P. has the largest disclosed position value at $334.4M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Frazier Life Sciences Management, L.P.'s linked filing trail.
Disclosed position value Top 5
ForGrowth NAP B.V. $272.13M
Bain Capital Life Sciences Invest... $239M
Frazier Life Sciences Management,... $334.4M
FCPM III SERVICES B.V. $223.85M
RA CAPITAL MANAGEMENT, L.P. $210.54M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ForGrowth NAP B.V.
3/4/5
10%+ Owner
—
denominator unverified
$272,125,599
10,656,172 shares
— 30 Dec 2024
Bain Capital Life Sciences Investors, LLC
3/4/5 13F
10%+ Owner · Company
—
mixed-class rows
$239,004,182
12,106,566 shares
mixed-class rows
— 13 Dec 2024
Frazier Life Sciences Management, L.P.
13F
Company
13F
—
mixed-class rows
$334,401,070
16,616,751 shares
mixed-class rows
— 31 Mar 2025
FCPM III SERVICES B.V.
13F
Company
13F
—
denominator unverified
$223,845,796
10,935,310 shares
— 31 Mar 2025
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
mixed-class rows
$210,540,725
10,472,271 shares
mixed-class rows
— 31 Mar 2025
VIKING GLOBAL INVESTORS LP
13F
Company
13F
—
denominator unverified
$142,850,591
6,978,534 shares
— 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
10
Shares
1,303,835
Indexed holders
10
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 indexed holders
10
Q2 2025 indexed holders
10
Indexed holder difference
0
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .